DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers

Area of Science:

• Epigenetics
• Oncology
• Virology

Background:

• Disrupted DNA methylation is a hallmark of cancer, including human papillomavirus (HPV)-driven head and neck cancer (HNC).
• HPV oncoproteins E6 and E7 interfere with DNA methyltransferase activity, leading to altered methylation patterns in HNC.
• Differential gene methylation in HPV-driven HNC impacts major cellular pathways, potentially driving cancer development and progression.

Purpose of the Study:

• To comprehensively review DNA methylation changes in HPV-driven HNC.
• To explore the diagnostic and therapeutic implications of these methylation alterations.

Main Methods:

• Literature review of studies on DNA methylation in HPV-driven HNC.
• Analysis of the role of HPV oncoproteins in altering host DNA methylation.
• Examination of methylation changes within the HPV genome itself.

Main Results:

• Numerous genes show differential methylation in HPV-driven HNC, affecting critical cellular functions.
• The HPV genome, particularly the long control region (LCR), is subject to methylation, influencing oncoprotein expression and carcinogenesis.
• Demethylation therapy shows promise in treating HPV-driven HNC.

Conclusions:

• DNA methylation plays a significant role in the pathogenesis of HPV-driven HNC.
• Methylation patterns in both host genes and the viral genome are crucial.
• Targeting DNA methylation offers potential diagnostic and therapeutic strategies for HPV-driven HNC.